🏭 TSM $8.2M LEAP — Second Whale in Two Days Buys June 2027 $560 Calls (Lower Strike, More Aggressive Entry)

Date: May 15, 2026 | Spot at Trade: $406.91 | Order Type: BTO — Long Call LEAP

---

Quick Take

At 12:34 ET on May 15, a single institutional buyer paid $8.2 million for 2,000 June 2027 $560 call contracts on TSM — Taiwan Semiconductor Manufacturing — with the stock trading at $406.91. The $560 strike sits ≈37% above spot with 13 months to expiry.

This is the second TSM whale LEAP in back-to-back trading sessions.

Yesterday — May 14, 2026 — a different (or the same) institutional buyer paid $10 million for 2,600 June 2027 $590 calls on TSM when the stock was trading at $418.71. Today's buyer is buying the same expiry but at a $30-lower strike, paying $40.90 per contract versus yesterday's $38.46. The combined open is now roughly $18.2 million in premium across 4,600 contracts — both positions expiring the third Friday of June 2027 — representing more than $265 million in notional directional exposure at full delta.

The 2-day stacking pattern is the central story here. When two separate institutional prints hit the same underlying, the same expiry, in consecutive sessions — with the second buyer choosing a more aggressive entry point (lower strike, lower breakeven) while the stock has pulled back roughly $12 from yesterday's all-time high — the market signal is unusually clear. This is not a single whale executing a one-off view. This is at minimum two large accounts, or one account averaging into a position at multiple strikes, both of them betting that TSMC trades materially above $600 before mid-June 2027.

The fundamental scaffolding is dense. Q1 2026 delivered $35.9B in revenue (+40.6% YoY) with a 66.2% gross margin — the best margin quarter on record — and management raised full-year 2026 guidance to greater than 30% USD revenue growth. The company's 2nm fabs are sold out at 78–104 week lead times, with Apple consuming ≈50% of N2 capacity for the A20 chip in iPhone 18 and NVIDIA having locked in more than 60% of TSMC's CoWoS advanced packaging capacity through 2027. The June 2027 expiry window captures Q2, Q3, and Q4 2026 earnings, the iPhone 18 launch, the Arizona Fab 2 tool-in, the NVIDIA Rubin platform ramp, and the first FY27 guidance cycle. Two sophisticated institutional buyers, on consecutive days, decided that is the right window to own.

---

Company Overview

TSM is the American depositary receipt for Taiwan Semiconductor Manufacturing Company (TSMC), headquartered in Hsinchu, Taiwan. TSMC is the world's largest dedicated contract semiconductor manufacturer and, by almost any measure, the single most critical company in the global chip supply chain.

Market dominance: TSMC controls ≈90% of global production of sub-7nm logic semiconductors and manufactures an estimated ≈99% of the chips used to train frontier AI models. At a ≈$2.11 trillion market capitalization as of May 2026, it ranks among the seven largest companies in the world. The stock printed an all-time high of $421.97 on May 14, 2026 — the same session as yesterday's $590 LEAP print — before pulling back slightly to $406.91 by the time today's $560 print hit the tape.

The node roadmap that no competitor can replicate: The process trajectory — N5 (mature), N3 (ramping), N2 (volume production started Q4 2025), N2P (targeted 2H 2026), A16 with backside power delivery (2027) — represents a multi-year technology lead over Samsung Foundry and Intel Foundry, both of which have failed to win meaningful external customer traction at 2nm-class nodes. Intel is conspicuously absent from TSMC's first N2 customer list, which includes Apple, AMD, NVIDIA, and MediaTek. That absence tells you everything about the competitive landscape.

2nm is sold out: N2 wafer ASPs are reportedly priced at ≈$30,000 per wafer — versus ≈$17,000 for N5 and ≈$24,000 for N3 — with 78–104 week lead times and full capacity booked through 2028. At those economics, every percentage point of N2 wafer revenue mix that replaces N5 is structurally margin-accretive. As N2 scales from the current 50,000 wafers per month toward the targeted 200,000 wafers per month in 2027, the gross margin expansion story becomes increasingly quantifiable.

Customer concentration driving the bull thesis: Apple holds ≈50% of 2026–2027 N2 wafer allocation for the A20 chip (iPhone 18, fall 2026) and M6 Mac chip families, per iDropNews. NVIDIA has locked in more than 60% of TSMC's 2026–2027 CoWoS capacity for its Rubin and Vera platforms, with CoWoS capacity expanding to 95,000 wafers per month by year-end 2026 and 135,000 by 2027, per Astute Group. Apple and NVIDIA together represent ≈38% of projected FY26 revenue — pricing power that is both the bull thesis and the single-customer concentration risk.

US expansion de-risks the geopolitical premium: TSMC has committed $165B in total Arizona investment following a White House agreement. Fab 21 Phase 1 (N4 process) is in high-volume production with Apple committed to more than 100 million Arizona-made chips in 2026. Phase 2 (N3 process) completed construction in April 2026 with tool-in beginning Q3 2026 and 3nm volume production targeted 2H 2027, per TrendForce. The U.S. tariff exemption TSMC currently enjoys is conditioned on continued Arizona investment execution — which means the fab milestones in this article are simultaneously technology catalysts and geopolitical risk management events.

Recent financial performance: The trailing 12-month return is approximately +120%. Q1 2026 revenue of $35.9B grew +40.6% YoY with a 66.2% gross margin. April 2026 monthly revenue came in at NT$410.73B / ≈$12.6B, +17.5% YoY — the second-highest monthly total on record and tracking toward the full-year >30% growth guide.

---

Trade Details

Option Chart: TSM Jun 2027 $560 Call

The Vol/OI ratio of 3.9x indicates notable fresh activity at this strike. At $40.90 per contract on 2,000 contracts, the position controls 200,000 underlying shares — representing roughly $81.4 million in notional equity at the trade-time spot of $406.91. With an estimated delta in the 0.22–0.27 range for a 37% OTM 13-month call, the effective directional exposure at trade entry is approximately $18M–$22M — delivered for $8.2M in premium, a characteristic LEAP leverage profile.

The $40.90 per-contract premium is moderately higher than yesterday's $38.46 per contract on the $590 strike. That is counterintuitive at first glance — a lower-strike call should cost more in absolute premium than a higher-strike call (all else equal), and the per-contract differential of $2.44 at a $30 strike difference confirms this is a slightly more in-the-money position than yesterday's print, with correspondingly more intrinsic (or more time value at a higher probability level). The buyer of today's $560 strike is accepting a lower breakeven ($600.90 vs. ≈$628.46 for the $590 strike) in exchange for paying a marginally higher per-contract cost. That is, by definition, a more aggressive entry — not less aggressive.

The Two-Day Pattern at a Glance

Both positions expire June 17, 2027. Combined, they represent 460,000 underlying shares and an estimated ≈$265 million in notional directional exposure at trade-entry delta.

Two interpretations coexist and are not mutually exclusive: (1) two separate institutional accounts independently reached the same June 2027 conviction in back-to-back sessions, each sizing at a slightly different risk level; or (2) a single fund is constructing a laddered entry — buying the $590 strike first when the stock is at $418, then the $560 strike the following day as the stock pulls back to $406 — averaging their cost basis across a strike range of $560–$590. Either narrative leads to the same conclusion: the combined $18.2M position is one of the most significant single-expiry LEAP commitments on TSM observable in recent history, and both legs were placed with full awareness that the current analyst consensus target (≈$416–$465) sits below both strikes.

---

Risk / Reward Profile

Maximum Loss, Breakeven, and Payoff Scenarios

• Maximum loss: $8,200,000 — the entire premium paid, if TSM closes below $560 on June 17, 2027
• Breakeven at expiry: $600.90 (strike $560 + $40.90 per-contract premium)
• Required rally to breakeven from trade-time spot: +47.7% from $406.91
• Position cannot generate a margin call: This is a fully paid long call — downside is capped at the $8.2M premium with no further liability

The position needs TSM to rally ≈48% from current levels to break even at expiry. That is an aggressive target — but several factors make it more credible than the raw percentage suggests. TSMC delivered +120% over the 12 months preceding this trade. The consensus sell-side target of ≈$416–$465 was set before Q1 2026's record-setting 66.2% gross margin and will almost certainly be revised upward into and after the Q2 print on July 16. The 13-month window is specifically designed to capture events — N2 scale-up, CoWoS expansion, iPhone 18 launch, FY27 initial guide — that have not yet been fully priced into forward earnings models.

Leverage and Capital Efficiency Comparison

At $40.90 per contract, controlling 100 shares of TSM for 13 months costs $4,090 in premium. Purchasing 100 shares outright at $406.91 would require $40,691 in capital. The option premium represents ≈10.1% of the notional equity value, providing approximately 9.9x notional leverage. If TSM rallies to $700 by expiry, the intrinsic value of $140 per contract represents a 242% return on the $40.90 option cost — while a direct equity holder at $406.91 earns +72%. That asymmetric upside, with a hard-capped maximum loss of $4,090 per contract, is the fundamental logic behind a LEAP rather than a stock purchase for a high-conviction medium-term view.

---

Greeks Analysis

For a 37.6% OTM 13-month call at approximately $40.90 per contract on a $406.91 underlying, the approximate Greek profile at trade entry:

• Delta: ≈0.22–0.27 — for every $1 move in TSM stock, the option gains or loses roughly $0.22–$0.27 in market value. Across 2,000 contracts (200,000 shares), the position has roughly $44,000–$54,000 in per-dollar spot sensitivity at trade entry. Delta is slightly higher than yesterday's $590-strike print due to the lower strike being less far out of the money.

• Gamma: low at current distance. Gamma becomes meaningful as TSM approaches the $480–$520 zone and becomes the primary driver of P&L once the position is within ≈10% of the strike. At current levels, large absolute price moves are required to materially shift the position's delta.

• Theta: approximately -$0.016 to -$0.026 per contract per day at current distance and IV levels. Across 2,000 contracts, the position carries roughly $3,200–$5,200 in daily time decay at current levels. Over 13 months, theta accelerates significantly in the final 60–90 days if the position remains out of the money. The position is most time-value-efficient if TSM trends higher steadily over the first 6–9 months rather than sitting flat and then spiking near expiry.

• Vega: substantial in absolute terms for a 13-month call at this distance. A 1-point rise in TSM implied volatility adds meaningful premium to the position, partially offsetting theta. The upcoming Q2 earnings on July 16 is a near-term IV catalyst — the position benefits from any implied volatility expansion event in the next few weeks regardless of direction, and then from realized volatility on the catalyst itself. The geopolitical premium embedded in longer-dated TSM options also means the position is structurally long a geopolitical event risk that the market has not yet fully resolved.

• Net Greek posture: Primarily long vega, long delta with a currently low gamma contribution. The ideal path for this position is a steady appreciation toward $500–$540 over the next 6–9 months (gradually building delta and gamma), then an acceleration above the strike driven by a strong Q2 or Q3 earnings print, an upward FY27 guide, or a structural consensus re-rating following iPhone 18 N2 validation. The worst path is TSM trading in a $390–$440 range through 2026 while IV compresses, eroding premium through both theta and vega simultaneously.

---

Catalyst Stack

The June 2027 expiry captures the maximum concentration of identifiable, high-magnitude TSMC catalysts across the 13-month window. The $560-strike buyer has explicitly chosen to own the following sequence of events:

Near-Term (Next 1–2 Months)

May 2026 Monthly Revenue Release (≈June 10, 2026) April's +17.5% YoY monthly revenue print represented a deceleration from Q1's +40.6% YoY pace. The May print is the first read on whether April was a seasonal anomaly or the start of a sustained deceleration. A recovery toward +25–30% YoY would confirm AI-demand durability; a second consecutive sub-20% print would raise questions about the full-year >30% FY26 guide and weigh on the position's near-term mark-to-market. YTD through April is +29.9%, still inside the guidance corridor, but the trend direction matters.

Q2 2026 Earnings Call (July 16, 2026) This is the single most near-term high-magnitude event for this position. Company guidance calls for Q2 revenue of $39.0B–$40.2B (+9–12% QoQ at midpoint), gross margin 65.5%–67.5%, and operating margin 56.5%–58.5%. The LEAP position needs: confirmation or upward revision of FY26 >30% growth guidance; continued margin expansion signaling an N2 mix shift; no tariff-exemption concerns from the Arizona buildout commentary; and any preliminary qualitative commentary on FY27 capex direction. A clean beat-and-raise on July 16 is the single event most likely to drive TSM from $406 toward $450–$480, which would materially increase the LEAP's mark-to-market value even if it remains out of the money.

June 2026 Monthly Revenue (≈July 10, 2026) The July 10 monthly report lands six days before the Q2 earnings call and will be read as a live preview of whether Q2 is tracking to the high end or low end of guidance. A strong June number closes the prior-deceleration narrative and reduces uncertainty heading into the earnings call — a compounding positive for the position.

Medium-Term (3–9 Months)

Arizona Fab 2 Tool-In (Q3 2026) Equipment installation begins Q3 2026 at TSMC's Arizona Fab 21 Phase 2 (N3 process), with 3nm volume production targeted for 2H 2027. A successful tool-in confirmation is a direct political signal that TSMC remains on track with its $165B Arizona investment commitment — the explicit condition for its current tariff exemption. TrendForce flagged four challenges on May 12 — water, regulatory complexity, visa delays, and labor shortages. Any delay disclosure increases tariff snap-back risk.

iPhone 18 Pro A20 Launch (September 2026) Apple is the lead N2 customer and holds ≈50% of 2026–2027 N2 wafer allocation. The iPhone 18 Pro will carry the A20 chip on N2 process — the first mass-market consumer device to ship at 2nm. A successful launch validates yield execution and sets the demand trajectory for 2027 N2 volumes. This is also the event that most directly accelerates N2 wafer revenue contribution in the Q3 2026 print (September ramp begins shipping in September, recognized in revenue immediately). An iPhone 18 demand cycle that outperforms expectations — analogous to iPhone 12's 5G supercycle — would be the single most powerful near-term re-rating catalyst for TSM consensus targets.

Q3 2026 Earnings and FY27 Capex Framework (Mid-October 2026) Q3 is traditionally the first venue where TSMC introduces preliminary FY27 capex and revenue framework commentary. CEO C.C. Wei has already signaled a "significantly higher" three-year capex trajectory beyond the prior $101B three-year total, per Datacenter Dynamics. Any preliminary FY27 capex number above $60B would be read as demand confirmation and drive a sell-side consensus upgrade wave — the scenario most likely to move the $560 strike into realistic range.

NVIDIA Rubin / Vera Platform Ramp (2H 2026 / 1H 2027) NVIDIA has locked in 800K–850K wafers for 2026 across Blackwell Ultra and Rubin architectures, with CoWoS packaging secured through 2027. The Rubin GPU platform will be the primary driver of CoWoS revenue at post-95K WPM capacity. Any Rubin demand upgrade or positive tape-out commentary from NVIDIA directly flows into TSM FY27 revenue estimates and supports the multi-stage argument for a $550+ stock price by mid-2027.

Long-Term (9–13 Months — In-Window for the LEAP)

Q4 2026 / FY26 Annual Close and FY27 Initial Guide (Mid-January 2027) This is the single most important milestone for a June 2027 expiry. The FY26 annual close is expected to show revenue in the ≈$158B range (+30%+ YoY). The FY27 initial guide — particularly the first capex number and qualitative commentary on N2 contribution as a percentage of wafer revenue — will set the multi-year consensus trajectory. This is when the market will decide whether TSM is a $500 or $600 stock on a 12-month forward view. If management confirms the "significantly higher" three-year capex trajectory with a number above $60B and N2 gross margin expansion above 67%, consensus models will begin converging on 2027 EPS estimates that support a $550–$620 stock price — which is exactly the geography the $560 strike occupies.

Q1 2027 Earnings (April 2027) The first quarter to show quantitatively visible N2 node revenue contribution at scale. N2 wafer pricing at ≈$30,000 — versus N5's ≈$17,000 — means that N2 reaching 15–20% of wafer revenue mix in Q1 2027 lifts blended gross margin from 66% toward 68–70%. At 70% gross margin on an annualized ≈$165–170B revenue base, TSMC's earnings power in 2027 would be approximately $18–22 per ADR — a range that justifies a $550–$650 stock price on 25–30x earnings. This is the fundamental path to the $560 strike becoming realistic by June 2027 even without a market re-rating premium.

Potential A16 Customer Announcements (2H 2026 / 2027) TSMC's A16 process with backside power delivery is targeted for 2027 production. NVIDIA is reportedly first to adopt A16 for 2028 datacenter products. Design-win announcements for A16 — which will likely emerge in 2H 2026 at the latest — extend the TSMC technology moat narrative through 2028 and materially reduce the risk that competitors can close the gap during the LEAP window. Each A16 design-win announcement is a structural positive for the long-term bull case.

---

Charts

TSM has returned approximately +120% over the trailing 12 months and printed an all-time high of $421.97 on May 14, 2026 — the same session in which yesterday's $590 LEAP was placed. The stock is pulling back modestly from that high as of today's trade at $406.91, which is precisely the environment in which the second LEAP buyer chose to step in at a lower strike. The chart reflects a market that has re-rated TSMC from a geopolitically discounted foundry to a core AI infrastructure holding: a re-rating the LEAP buyers on both days are betting continues through a second leg as N2 revenue contribution scales through 2027.

---

The gamma exposure (GEX) profile maps the current dealer hedging landscape and the strike levels where market-maker activity creates natural support and resistance. For both LEAP positions — with 13 months to expiry — near-term gamma dynamics do not directly pin or constrain the position. What the chart illuminates is the structural strike wall geography: the concentration of call open interest at higher strikes confirms the market has been pricing in a sustained bullish scenario. Key resistance zones visible in the GEX profile around $440–$460 represent dealer hedging friction that, once cleared, can generate upward momentum feedback. For the LEAP at $560, clearing those near-term resistance levels within 3–6 months would materially increase the position's mark-to-market probability.

---

The implied move chart shows how the options market is pricing TSM volatility across expirations. Near-term IV reflects the Q2 earnings catalyst window (July 16, 2026), while longer-dated term structure captures both the structural AI-demand premium and the Taiwan geopolitical tail risk discount. The $560 strike sits outside any near-term single-event implied move cone — which is by design. Both LEAP buyers are purchasing time: the 13-month expiry provides enough runway for multiple large-magnitude catalyst events to cumulatively close the distance to $560 even if no single event is sufficient on its own. TSM's IV structure also embeds a geopolitical premium in longer-dated contracts that means neither the $560 nor the $590 LEAP was purchased "cheaply" in a volatility-adjusted sense — but both buyers have concluded the directional upside from the catalyst stack justifies the embedded IV cost.

---

Risk Factors

Both LEAP positions require a ≈40–50% rally from current levels just to break even at expiry. The following risks are material to that scenario.

Section 232 Tariff Risk (Active and Conditional)

TSMC's current exemption from Section 232 chip tariffs is explicitly conditioned on continued Arizona investment execution. Commerce Secretary Lutnick has stated foreign chipmakers without U.S. capex commitments could face up to 100% tariffs. TrendForce flagged four challenges in the Arizona buildout on May 12, 2026 — water supply in the desert, regulatory complexity, visa processing delays for Taiwanese engineers, and U.S. labor shortages. Any public acknowledgment of timeline slippage on Fab 2 tool-in or Phase 3 groundbreaking could create political pressure for tariff reinstatement. A 25% chip tariff on TSMC products would cascade through customer pricing, volume commitments, and gross margin — a directly adverse scenario for both LEAP positions.

Geopolitical / Taiwan Strait Risk (In-Window)

The CIA has disclosed that President Xi Jinping ordered the PLA to be ready for a Taiwan invasion by 2027 — a timeline that falls directly within both LEAPs' June 2027 expiry window. A military escalation scenario, even a short of a full invasion (naval quarantine, blockade, kinetic action), would make both LEAP positions expire worthless regardless of TSMC's fundamental performance. Bloomberg Economics estimates a Taiwan conflict at ≈$10 trillion in global economic damage — exceeding COVID-19 in scale. This is the irreducible tail risk for any TSM long position, particularly for instruments with expiry inside the 2027 window. The LEAP buyers are knowingly paying for this embedded IV and betting the fundamental catalysts overwhelm the geopolitical discount.

Revenue Deceleration Signal

April 2026 monthly revenue grew +17.5% YoY — the first observable deceleration from Q1's +40.6% YoY pace. If May and June monthly prints confirm a continued deceleration toward the +15–18% YoY range, analysts will begin questioning whether the >30% FY26 guide is achievable and potentially cutting consensus estimates ahead of the July 16 Q2 call. That de-risking dynamic would pressure the stock before the first major catalyst event, eroding the LEAP positions' near-term mark-to-market value at precisely the moment they are most vulnerable to time decay.

Consensus Target Gap

Street consensus on TSM carries a 12-month aggregate target of approximately $416.67 to $465, with the highest single target at $480–$500. Today's $560 breakeven sits $95–$145 above the current consensus target range. For the LEAP to generate profit, TSM must exceed current sell-side consensus by at least 20% — which requires either a significant beat-and-raise cycle through multiple quarters, a structural consensus upgrade driven by FY27 capex guidance, or both. This is not a moderately OTM position betting on a conservative target. Both whale buyers are explicitly positioned beyond where the street currently sits.

Customer Concentration Risk

Apple and NVIDIA together represent ≈38% of projected FY26 revenue. An iPhone 18 launch disappointment — whether from demand weakness, A20 yield issues, or a product recall — would reduce N2 wafer consumption at precisely the moment when N2 is supposed to begin lifting blended gross margins. A NVIDIA Rubin demand shortfall, or any H100/H200/Blackwell digestion pause at hyperscalers, would reduce CoWoS utilization and Q3–Q4 2026 revenue. Neither event alone prevents the $560 strike from eventually being approached in a sustained bull scenario — but either would delay the timeline materially, increasing theta drag on both positions.

ARK Profit-Taking as a Contrarian Signal

ARK Invest sold 41,540 TSM shares (≈$16.6M) on May 14, 2026 at the all-time high — the same session as yesterday's $590 LEAP print. ARK selling at an all-time high is consistent with disciplined portfolio rebalancing, not a thesis reversal, and ARK remains a TSM holder. But the optics — long-only funds taking profit at record levels on the same day an institutional buyer makes a $10M LEAP bet — reflect a market where sentiment divergence is widening. The ARK sale is not a negative catalyst, but it is a reminder that the most obvious near-term opportunity (booking an all-time-high gain in a +120% position) was taken by at least one major institutional holder on May 14.

---

What to Watch

The following milestones are the operative checkpoints for evaluating whether both LEAP positions are tracking toward profitability:

Within 30 days — May Revenue Release (≈June 10): A recovery from April's +17.5% YoY toward +25% or better would confirm AI-demand durability and re-accelerate the bull narrative. A second consecutive sub-20% print would be a warning signal and the first genuine reason to question whether the full-year >30% guide is achievable.

Within 60 days — Q2 Earnings (July 16): This is the primary near-term inflection for both positions. The market needs Q2 revenue to meet or beat the $39.0B–$40.2B guide and management to maintain or raise FY26 guidance above 30% growth. A strong margin outcome (gross margin at the high end of 65.5%–67.5%) combined with any preliminary FY27 language would be the event most likely to drive TSM toward $450–$480 and meaningfully reduce the distance to the $560 and $590 strikes. A miss — even a modest one — would erode both positions' mark-to-market value and extend their time decay period.

Within 90 days — Arizona Fab 2 Tool-In (Q3 2026): Equipment installation on schedule is not just a technology milestone — it is a tariff-exemption milestone. Any public acknowledgment of meaningful delay on the Fab 2 timeline creates political risk for the exemption and is a macro risk event for both positions. Monitor TSMC press releases and any Commerce Department commentary around Fab 2 progress through September.

Within 6 months — iPhone 18 Launch (September 2026): The A20 chip on N2 process is the single largest volume validation event for TSMC's 2nm ramp. Pre-launch demand signals from Apple's supply chain (Foxconn build orders, component order data, carrier pre-order volumes) beginning in July–August 2026 will be read as leading indicators. An iPhone 18 Pro cycle that matches or exceeds the iPhone 12 supercycle would be strongly positive for both LEAP positions.

Within 9 months — Q3 2026 Earnings and FY27 Framework (October 2026): The first venue for FY27 capex and revenue framework commentary. If management confirms the "significantly higher" three-year capex trajectory with a number above $60B, sell-side consensus will begin modeling 2027 EPS in the $18–22 per ADR range, which supports a stock price well above $500. A consensus upgrade wave toward $520–$560 would begin to bring the $560 LEAP strike into realistic reach on a 12-month view.

Within 12 months — Q4 2026 Annual Close + FY27 Initial Guide (January 2027): The single most important event for both positions. A FY26 revenue close at ≈$158B+ combined with a FY27 initial guide above 20% YoY growth and explicit N2 margin contribution commentary is what converts the $560 breakeven from "requires a major re-rating" to "consensus could get there." If the January 2027 call produces a consensus target upgrade to $520–$560, the option's remaining time value will reflect materially higher probability of expiring in the money, and both positions' mark-to-market values could approach or exceed breakeven before the final expiry date.

Final 6 months — Q1 2027 Earnings (April 2027) through June 17, 2027 Expiry: N2 wafer revenue contribution should be quantitatively visible in Q1 2027 gross margin at meaningful scale. If N2 reaches 15–20% of wafer revenue at $30,000+ pricing, blended margin expansion toward 68–70% becomes the new consensus expectation and the fundamental earnings power argument for a $550–$600+ stock becomes defensible on standard valuation multiples. Conversely, any N2 yield disappointment or capex overrun that pressures margins in Q1 2027 would be the final negative catalyst that could render both LEAP positions unlikely to recover before June 17.

---

Disclosure

Options trading involves substantial risk and is not suitable for all investors. Long call positions can expire entirely worthless, resulting in a 100% loss of the premium paid. The strategies discussed in this article — deep out-of-the-money LEAP calls — are complex instruments involving significant time decay (theta), sensitivity to changes in implied volatility (vega), and a low probability of reaching intrinsic value at expiration without a large directional move in the underlying. A position that is ≈37–41% out-of-the-money with 13 months to expiry requires an exceptionally large directional move to generate any profit at expiration.

Nothing in this article constitutes investment advice, a recommendation to buy or sell any security, or a solicitation of any investment. All analysis is for informational and educational purposes only. Past performance of TSMC's stock or any related instrument is not indicative of future results. Options data sourced from public market feeds. All premium figures, strikes, Greeks estimates, and scenario analyses are subject to change with market conditions and are presented for educational context only.

All geopolitical and macroeconomic risk factors described herein involve substantial uncertainty. The Section 232 tariff framework is subject to executive discretion. The 2027 geopolitical timeline represents an analytical reference point, not a prediction. Always consult a qualified financial professional before making investment decisions. Verify all prices, strikes, and market data independently before executing any trade.

Published: May 15, 2026 | OptionLabs